{"filing":{"accession_number":"0001723464-26-000054","cik":"0001723464","ticker":"BHST","company_name":"BIOHARVEST SCIENCES INC.","form":"6-K","filing_date":"2026-09-15","report_date":"2026-09-15","primary_document":"bhsc_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1723464/000172346426000054/bhsc_6k.htm"},"events":[{"id":33695,"run_id":30995,"accession_number":"0001723464-26-000054","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"BioHarvest Sciences announced its dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing, with Common Shares beginning trading on TASE on September 8, 2026. This is a material operational and strategic event — a significant capital markets milestone involving listing on a major foreign exchange — but does not fit the specific event-type categories (not M\u0026A, not a financial obligation, not governance-related in the traditional sense). The disclosure clearly affects investor assessment of the company's market access and strategic positioning.","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-09-15","form":"6-K","submitted_at":null,"items":[{"id":37211,"accession_number":"0001723464-26-000054","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioHarvest Sciences announced its dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing, with Common Shares beginning trading on TASE on September 8, 2026. This is a material operational and strategic event — a significant capital markets milestone involving listing on a major foreign exchange — but does not fit the specific event-type categories (not M\u0026A, not a financial obligation, not governance-related in the traditional sense). The disclosure clearly affects investor assessment of the company's market access and strategic positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-15T21:08:37.405014+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37211,"accession_number":"0001723464-26-000054","item_number":"EX-99.1","item_title":"bhsc_ex991.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"BioHarvest Sciences announced its dual listing on the Tel Aviv Stock Exchange (TASE) alongside its existing Nasdaq listing, with Common Shares beginning trading on TASE on September 8, 2026. This is a material operational and strategic event — a significant capital markets milestone involving listing on a major foreign exchange — but does not fit the specific event-type categories (not M\u0026A, not a financial obligation, not governance-related in the traditional sense). The disclosure clearly affects investor assessment of the company's market access and strategic positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-15T21:08:37.405014+00:00","company_name":"BIOHARVEST SCIENCES INC.","ticker":"BHST","filing_date":"2026-09-15"}]}